← Back to Clinical Trials
RecruitingNCT05642858
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
◆ AI Clinical Summary
Plain-language summary for patients
Trial Parameters
ConditionHIV
SponsorUniversity of California, San Francisco
Study TypeINTERVENTIONAL
PhaseN/A
Enrollment260
SexALL
Min Age40 Years
Max AgeN/A
Start Date2023-03-12
Completion2025-12-01
Interventions
Digital Educational Messaging
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The overall objective is to evaluate the efficacy of educational text messages to reduce cardiovascular risk among persons living with HIV (PLWH).
Eligibility Criteria
Inclusion Criteria: * HIV positive * At least 40 years of age * English-speaking Exclusion Criteria: * Existing clinical atherosclerotic cardiovascular disease (ASCVD) * Pregnant * Unwilling/unable to provide informed consent * Does not own a smartphone
Related Trials
NCT05404958
Systems Analysis and Improvement Approach to Improve Integration of HIV Prevention and Treatment Ser
View Trial →
NCT06617091
A Trial of a Gorilla Adenovirus Vectored Networked Epitopes Vaccine, Administered to Healthy Adults
View Trial →
NCT05642858
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology